Evidence map›Paper›PMID 40066222›Full record

ReviewMedComm2025

RNA Modification in Metabolism.

Yadi Liu, Zhongyan Sun, Dingkun Gui, Yonghua Zhao, Youhua Xu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. The Role of NMedComm · 2026
    Review
  2. FTO-modulated mJournal of translational medicine · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Yadi LiuFaculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines Macau University of Science and Technology Taipa Macao SAR PR China.
Zhongyan SunFaculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines Macau University of Science and Technology Taipa Macao SAR PR China.
Dingkun GuiDepartment of Nephrology Shanghai Jiao Tong University Affiliated Sixth People's Hospital Shanghai PR China.
Yonghua ZhaoInstitute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine University of Macau Taipa Macao SAR PR China.
Youhua XuFaculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines Macau University of Science and Technology Taipa Macao SAR PR China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epigenetic regulation in disease development has been witnessed within this decade. RNA methylation is the predominant form of epigenetic regulation, and the most prevalent modification in RNA is N6-methyladenosine (m

Indexed as

epigenomicsmetabolic diseasesN6‐methyladenosineRNA modifications

Identifiers

PMID40066222
PMCPMC11892166

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.